Record overview
Status and phase
Status: COMPLETED
Phase: PHASE2
Sponsor: Institut de Cancérologie de Lorraine
Condition: Pancreatic Carcinoma
NCT02676349
Neoadjuvant mFolfirinox With or Without Preoperative Concomitant Chemoradiotherapy in Patients With Borderline Resectable Pancreatic Carcinoma (PANDAS-PRODIGE 44)
Public trial-level signal summary for this oncology Phase 2 record.
Signal summary
Public flags
Status signal: Low Signal
Timeline signals: None
Results signal: Completed No Results Found Signal
Operational burden: None
Stopped reason
Context when available
No stop reason available in the current public record.